Target intelligence / Profile preview

Xanthomonadaceae family bacterium

Molecular classification
Bacterium, Gram-negative bacterium, Gammaproteobacteria (class), Pseudomonadota (phylum)
01

Overview

The Xanthomonadaceae are a family of Gram-negative bacteria within the order Xanthomonadales and class Gammaproteobacteria. This group includes several important plant pathogens, such as species from the genus *Xanthomonas* and *Xylella*, which cause diseases in crops like rice, citrus, tomatoes, bananas, and coffee. Some members of this family—particularly those in the genus *Stenotrophomonas*—are also known for causing multidrug-resistant opportunistic infections in immunocompromised patients. The family was previously known as Lysobacteraceae. Note on correctness: "Xanthomonadaceae family bacteria" refers to a broad taxonomic group rather than a specific molecular target or receptor. It is not considered a therapeutic target like an enzyme or receptor but rather encompasses many bacterial species with diverse roles and characteristics. Therefore, it is not appropriate to treat "Xanthomonadaceae family bacteria" as a single druggable molecular entity; instead, individual species or proteins within these bacteria may serve as specific targets. If you need structured information about an individual protein or gene product from this bacterial group that serves as a therapeutic target (e.g., an effector protein from *Xanthomonas*), please specify further.

Other names
Lysobacteraceae (previous name)Xanthomonadaceae bacteriaMembers of the Xanthomonadaceae family
02

Biological functions

Plant pathogenesisOpportunistic human infection (in some genera, e.g., Stenotrophomonas)Nitrate reduction (in some genera, e.g., Stenotrophomonas)
03

Disease associations

Infection (notably plant diseases; opportunistic infections in immunocompromised humans)
04

Safety considerations

Multidrug resistance in some members such as Stenotrophomonas

Beyond the preview

Go deeper on Xanthomonadaceae family bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xanthomonadaceae family bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call